World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
142
Citations
213920
World Ranking
1528
National Ranking
155

Overview

Jonathan A C Sterne is affiliated with the University of Bristol in the United Kingdom. Their research primarily focuses on the field of Medicine, with a significant number of publications related to Infectious Diseases, Epidemiology, Health, Neurology, and Emergency Medicine.

The scientist's work covers several main topics including:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • Long-Term Effects of COVID-19
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • COVID-19 and Mental Health

Jonathan A C Sterne has contributed to multiple recent research papers. These include:

  • Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19, 2020, JAMA
  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results, 2020, New England Journal of Medicine
  • Collider bias undermines our understanding of COVID-19 disease risk and severity, 2020, Nature Communications
  • The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis, 2022, EClinicalMedicine
  • A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E), 2024, Environment International

The scientist has published one book titled Technics in 2024 through Amsterdam University Press.

Jonathan A C Sterne frequently collaborates with several researchers. Their most common co-authors are:

  • Venexia Walker
  • Ben Goldacre
  • Elsie Horne
  • Amir Mehrkar
  • Rachel Denholm

Publication venues that regularly feature their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • BMJ
  • The Lancet HIV
  • UNC Libraries
  • Nature Communications

Best Publications

  • The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

    Julian P T Higgins;Douglas G Altman;Peter C Gøtzsche;Peter Jüni

  • ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

    Jonathan A. C. Sterne;Miguel A Hernan;Barnaby C Reeves;Jelena Savovic;Jelena Savovic

  • RoB 2: a revised tool for assessing risk of bias in randomised trials.

    Jonathan A.C. Sterne;Jelena Savović;Jelena Savović;Matthew J. Page;Roy G. Elbers

  • QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

    Penny F. Whiting;Anne W.S. Rutjes;Marie E. Westwood;Susan Mallett

  • Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.

    Jonathan A C Sterne;Ian R White;John B Carlin;Michael Spratt

  • Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

    Jonathan A C Sterne;Alex J Sutton;John P A Ioannidis;Norma Terrin

  • Essential Medical Statistics

    Betty R. Kirkwood;Jonathan A. C. Sterne

  • Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.

    Debbie A. Lawlor;Roger M. Harbord;Jonathan A. C. Sterne;Nicholas J Timpson

  • Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.

    Jonathan A.C Sterne;Matthias Egger

  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

    Hongchao Pan;Richard Peto;Ana-Maria Henao-Restrepo

  • Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

    Lesley Wood;Matthias Egger;Lise Lotte Gluud;Kenneth F Schulz

  • Publication and related bias in meta-analysis : power of statistical tests and prevalence in the literature

    Jonathan A.C Sterne;David Gavaghan;Matthias Egger

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

    Sterne Jac.;S Murthy;J V Diaz

  • A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints

    Roger M. Harbord;Matthias Egger;Matthias Egger;Jonathan A. C. Sterne

  • Sifting the evidence—what's wrong with significance tests?

    Jonathan A C Sterne;D R Cox;George Davey Smith

  • Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.

    Jonathan A C Sterne;Matthias Egger;George Davey Smith

  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

    R Hogg;V Lima;J Sterne;S Grabar

  • Assessing risk of bias in a randomized trial

    Julian Pt Higgins;Jelena Savović;Matthew J Page;Roy G Elbers

  • Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses (Annals of Internal Medicine (2008) 149, (219))

    Lise L. Gluud;Kristian Thorlund;Christian Gluud;Lesley Woods

Frequent Co-Authors

Margaret T May
Margaret T May University of Bristol
Matthias Egger
Matthias Egger University of Bern
Amy C. Justice
Amy C. Justice Yale University
Julian P T Higgins
Julian P T Higgins University of Bristol
Kate Tilling
Kate Tilling University of Bristol
George Davey Smith
George Davey Smith University of Bristol
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
François Dabis
François Dabis University of Bordeaux

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a variety of respected online degrees and career pathways, especially for those seeking flexibility or a faster path to clinical roles. For nurses pursuing advanced leadership or specialized clinical roles, options like the 1 year dnp program online make it possible to earn a Doctor of Nursing Practice in just 12 months, helping accelerate professional growth.

Cost can be a major factor. Many aspiring healthcare professionals search for the cheapest dnp programs to obtain a doctoral degree without accruing significant debt. Similarly, those looking to quickly enter the workforce often explore what is the fastest way to become an lpn, finding online and accelerated Licensed Practical Nurse pathways.

Specialization opportunities also exist—such as programs to become a Psychiatric Mental Health Nurse Practitioner. Accelerated options help qualified professionals enter this field rapidly, with the psych nurse practitioner programs providing flexible, online study opportunities. Exploring these online degrees can give students and working professionals the chance to advance or pivot in their healthcare careers from almost anywhere.

Best Scientists Citing Jonathan A C Sterne

Trending Scientists